Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Infectious Diseases Therapeutics Market Research Reports

Titlepublishedprice

Bacterial Pneumonia-Pipeline Insights, 2017

By Delve Insight
"...... nical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA desig......"
01-Jan-2017$1250

Haemophilus Influenzae Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... ophilus Influenzae Infections Report is to understand the market and pipeline status of the drugs around the Haemophilus Influenzae Infections to explore the generic development opportunities, licensing opportunities and to gain competitive advantage......"
01-Jan-2017$2000

Clostridium difficile (CDID) - Epidemiology Forecast To 2023

By Delve Insight
"...... lostridium difficile (CDID) prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with the Clostridium di......"
01-Jan-2017$2750

Leishmaniasis (Kala-Azar)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... s (Kala-Azar) Report is to understand the market and pipeline status of the drugs around the Leishmaniasis (Kala-Azar) to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline s......"
01-Jan-2017$2000

Rhinosinusitis-Pipeline Insights, 2017

By Delve Insight
"...... , Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations de......"
01-Jan-2017$1250

Rhinovirus Infection-Pipeline Insights, 2017

By Delve Insight
"...... linical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA des......"
01-Jan-2017$1250

Lyme Disease-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... understand the market and pipeline status of the drugs around the Lyme Disease to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight's Report pr......"
01-Jan-2017$2000

Rotavirus Infections-Pipeline Insights, 2017

By Delve Insight
"...... linical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA des......"
01-Jan-2017$1250

Rubella-Pipeline Insights, 2017

By Delve Insight
"...... se II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveIn......"
01-Jan-2017$1250

Influenza A Infections-Pipeline Insights, 2017

By Delve Insight
"...... re-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA......"
01-Jan-2017$1250

Avail upto 50% Discount on below Publisher Reports.